Ferroptosis-centered Drug Response Information
General Information of the Drug (ID: ferrodrug0398)
| Name |
Shuganning injection
|
||||
|---|---|---|---|---|---|
| Drug Type |
Traditional Chinese Medicin
|
||||
Full List of Ferroptosis Target Related to This Drug
Heme oxygenase 1 (HMOX1)
| In total 1 item(s) under this Target | |||||
| Experiment 1 Reporting the Ferroptosis-centered Drug Act on This Target | [1] | ||||
| Target for Ferroptosis | Driver/Suppressor | ||||
| Responsed Disease | Breast cancer | ICD-11: 2C60 | |||
| Pathway Response | Fatty acid metabolism | hsa01212 | |||
| Ferroptosis | hsa04216 | ||||
| Cell Process | Cell ferroptosis | ||||
| Cell proliferation | |||||
| In Vitro Model | SK-BR-3 cells | Breast adenocarcinoma | Homo sapiens | CVCL_0033 | |
| MDA-MB-231 cells | Breast adenocarcinoma | Homo sapiens | CVCL_0062 | ||
| MDA-MB-468 cells | Breast adenocarcinoma | Homo sapiens | CVCL_0419 | ||
| BT-549 cells | Invasive breast carcinoma | Homo sapiens | CVCL_1092 | ||
| MCF-10A cells | Normal | Homo sapiens | CVCL_0598 | ||
| 786-O cells | Renal cell carcinoma | Homo sapiens | CVCL_1051 | ||
| A2780 cells | Ovarian endometrioid adenocarcinoma | Homo sapiens | CVCL_0134 | ||
| HCT 116 cells | Colon carcinoma | Homo sapiens | CVCL_0291 | ||
| Hep-G2 cells | Hepatoblastoma | Homo sapiens | CVCL_0027 | ||
| A-549 cells | Lung adenocarcinoma | Homo sapiens | CVCL_0023 | ||
| L-02 cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | ||
| WPMY-1 cells | Normal | Homo sapiens | CVCL_3814 | ||
| U-87MG cells | Glioblastoma | Homo sapiens | CVCL_0022 | ||
| HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 | ||
| In Vivo Model |
MDA-MB-231 cells resuspended in PBS (2 x 106/100 m1) were injected subcutaneously into bothhind limbsof 4-6 weeks old femalenude mice. A week later, SGNI was administrated byintraperitoneal injectionat a dose of 112.5 mg/kg/3 d.
Click to Show/Hide
|
||||
| Response regulation | Shuganning injection (SGNI) induced a ferroptotic cell death of Triple-negative breast cancer (TNBC) cells. Mechanistically, SGNI induced ferroptosis was dependent on HO-1, which promotes intracellular labile iron pool accumulation, and was alleviated by HO-1 knockdown and inhibition by tin protoporphyrin IX. | ||||
